Adiposity and risk for hypertension: Does location matter?

Journal of the American College of Cardiology

Volumn 64, Issue 10, 2014, Pages 1003-1004

  Krakoff, Lawrence R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Magnetic resonance; Obesity; Retroperitoneum

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ADRENAL INCIDENTALOMA; BODY MASS; CARDIOVASCULAR RISK; CUSHING SYNDROME; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RADIODENSITOMETRY; RETROPERITONEAL FAT; RISK ASSESSMENT; SODIUM RETENTION; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BODY FAT DISTRIBUTION; FEMALE; MAGNETIC RESONANCE HYPERTENSION; MALE; RETROPERITONEUM; STATISTICS;

MAGNETIC RESONANCE HYPERTENSION; OBESITY; RETROPERITONEUM;

BODY FAT DISTRIBUTION; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION; MALE; OBESITY;

EID: 84908213848     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.005     Document Type: Editorial

References (10)

1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
2. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham Experience. Arch Intern Med 2002;162:1867-72.
3. Pardo Silva MC, De Laet C, Nusselder WJ, Mamun AA, Peeters A. Adult obesity and number of years lived with and without cardiovascular disease. Obesity 2006;14:1264-73.
4. Dhaliwal SS, Welborn TA. Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores. Am J Cardiol 2009;103:1403-7.
5. Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014;56:369-81.
6. Chandra A, Neeland IJ, Berry JD, et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol 2014;64: 997-1002.
7. Hall JE, Granger JP, do Carmo JM, et al. Hypertension: physiology and pathophysiology. Compr Physiol 2012;2:2393-442.
8. Smyth A, Collins CS, Thorsteinsdottir B, et al. Page kidney: etiology, renal function outcomes and risk for future hypertension. J Clin Hypertens (Greenwich) 2012;14:216-21.
9. Peppa M, Koliaki C, Raptis SA. Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications. J Intern Med 2010;268:555-66.
10. Greenfield JR, Miller JW, Keogh JM, et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009;360:44-52.